炎症性肠病患者的大麻使用模式:一项基于人群的分析。

Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis.

作者信息

Weiss Alexandra, Friedenberg Frank

机构信息

Temple University Hospital, Internal Medicine Department, 3401 N Broad St, Philadelphia, PA 19140, United States.

Temple University Hospital, Gastroenterology Department, 3401 N Broad St, Philadelphia, PA 19140, United States.

出版信息

Drug Alcohol Depend. 2015 Nov 1;156:84-89. doi: 10.1016/j.drugalcdep.2015.08.035. Epub 2015 Sep 14.

Abstract

BACKGROUND

Tobacco use patterns and effects in patients with Inflammatory Bowel Disease have been extensively studied, however the role and patterns of cannabis use remains poorly defined. Our aim was to evaluate patterns of marijuana use in a large population based survey.

METHODS

Cases were identified from the NHANES database from the National Center for Health Statistics for the time period from January, 2009 through December, 2010 as having ulcerative colitis or Crohn's disease, and exact matched with controls using the Propensity Score Module of SPSS, based on age, gender, and sample weighted using the nearest neighbor method.

RESULTS

After weighting, 2084,895 subjects with IBD and 2013,901 control subjects were identified with no significant differences in demographic characteristics. Subjects with IBD had a higher incidence of ever having used marijuana/hashish (M/H) (67.3% vs. 60.0%) and an earlier age of onset of M/H use (15.7 years vs. 19.6 years). Patients with IBD were less likely to have used M/H every month for a year, but more likely to use a heavier amount per day (64.9% subjects with IBD used three or more joints per day vs. 80.5% of subjects without IBD used two or fewer joints per day). In multivariable logistic regression, presence of IBD, male gender, and age over 40 years predicted M/H use.

CONCLUSION

Our study is the first to evaluate marijuana patterns in a large-scale population based survey. Older, male IBD patients have the highest odds of marijuana use.

摘要

背景

烟草使用模式及其在炎症性肠病患者中的影响已得到广泛研究,然而大麻使用的作用和模式仍不明确。我们的目的是在一项基于大规模人群的调查中评估大麻使用模式。

方法

从美国国家卫生统计中心的NHANES数据库中识别出2009年1月至2010年12月期间患有溃疡性结肠炎或克罗恩病的病例,并使用SPSS的倾向得分模块,根据年龄、性别以及采用最近邻法进行样本加权,与对照组进行精确匹配。

结果

加权后,确定了2084895名炎症性肠病患者和2013901名对照对象,他们在人口统计学特征上无显著差异。炎症性肠病患者曾经使用过大麻/哈希什(M/H)的发生率更高(67.3%对60.0%),且开始使用M/H的年龄更早(15.7岁对19.6岁)。炎症性肠病患者不太可能连续一年每月使用M/H,但更有可能每天使用量较大(64.9%的炎症性肠病患者每天吸食三根或更多大麻烟,而80.5%的非炎症性肠病患者每天吸食两根或更少大麻烟)。在多变量逻辑回归分析中,患有炎症性肠病、男性以及年龄超过40岁是使用M/H的预测因素。

结论

我们的研究是首次在基于大规模人群的调查中评估大麻使用模式。年龄较大的男性炎症性肠病患者使用大麻的几率最高。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索